ES2134267T3 - 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion. - Google Patents
1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion.Info
- Publication number
- ES2134267T3 ES2134267T3 ES93921243T ES93921243T ES2134267T3 ES 2134267 T3 ES2134267 T3 ES 2134267T3 ES 93921243 T ES93921243 T ES 93921243T ES 93921243 T ES93921243 T ES 93921243T ES 2134267 T3 ES2134267 T3 ES 2134267T3
- Authority
- ES
- Spain
- Prior art keywords
- vitamin
- alpha
- converted
- preparation
- dihidroxi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0036—Nitrogen-containing hetero ring
- C07J71/0042—Nitrogen only
Abstract
SE DESCRIBE UNA VITAMINA D2 1 ,24(S)-DIHIDROXI UTIL COMO COMPONENTE ACTIVO EN COMPOSICIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE DESORDENES EN EL METABOLISMO DE CALCIO Y DE LA PIEL. LA INVENCION TAMBIEN INCLUYE LA PREPARACION DE VITAMINA D2 1 ,24(S)-DIHIDROXI SINTETICA PARTIENDO DE ERGOSTEROL QUE SE CONVIERTE MEDIANTE 6 PASOS EN 24-HIDROXIERGOSTEROL. ESTE ULTIMO ES IRRADIADO Y CONVERTIDO TERMICAMENTE EN VITAMINA D2 24-HIDROXI QUE SE CONVIERTE A SU VEZ MEDIANTE 6 PASOS EN VITAMINA D2 1 ,24(S)-DIHIDROXI. LA SINTESIS TAMBIEN PRODUCE NUEVOS INTERMEDIARIOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94024692A | 1992-08-28 | 1992-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2134267T3 true ES2134267T3 (es) | 1999-10-01 |
Family
ID=25474483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93921243T Expired - Lifetime ES2134267T3 (es) | 1992-08-28 | 1993-08-30 | 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6143910A (es) |
EP (1) | EP0614456B1 (es) |
JP (1) | JP3179495B2 (es) |
AT (1) | ATE181062T1 (es) |
AU (2) | AU4841193A (es) |
CA (1) | CA2121689C (es) |
DE (1) | DE69325253T2 (es) |
DK (1) | DK0614456T3 (es) |
ES (1) | ES2134267T3 (es) |
GR (1) | GR3030939T3 (es) |
WO (1) | WO1994005630A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5602116A (en) * | 1988-08-02 | 1997-02-11 | Bone Care International, Inc. | Method for treating and preventing secondary hyperparathyroidism |
US6538037B2 (en) | 1991-01-08 | 2003-03-25 | Bone Care International, Inc. | Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2 |
US6376479B1 (en) | 1995-04-03 | 2002-04-23 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
US6242434B1 (en) | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
TWI247001B (en) | 1996-07-01 | 2006-01-11 | Chugai Pharmaceutical Co Ltd | The method for purifying vitamin d derivatives and its crystalline products |
US20020128240A1 (en) * | 1996-12-30 | 2002-09-12 | Bone Care International, Inc. | Treatment of hyperproliferative diseases using active vitamin D analogues |
US6566353B2 (en) | 1996-12-30 | 2003-05-20 | Bone Care International, Inc. | Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
US6503893B2 (en) | 1996-12-30 | 2003-01-07 | Bone Care International, Inc. | Method of treating hyperproliferative diseases using active vitamin D analogues |
US6573256B2 (en) | 1996-12-30 | 2003-06-03 | Bone Care International, Inc. | Method of inhibiting angiogenesis using active vitamin D analogues |
AU762481C (en) * | 1998-03-27 | 2004-08-19 | Oregon Health Sciences University | Vitamin D and its analogs in the treatment of tumors and other hyperproliferative disorders |
US6362350B1 (en) | 1999-07-01 | 2002-03-26 | Wisconsin Alumni Research Foundation | Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof |
CA2414407A1 (en) * | 2000-07-18 | 2002-01-24 | Bone Care International, Inc. | Stabilized 1.alpha.-hydroxy vitamin d |
PL212660B1 (pl) * | 2000-10-27 | 2012-11-30 | Leo Pharma As | Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie |
US7094775B2 (en) * | 2004-06-30 | 2006-08-22 | Bone Care International, Llc | Method of treating breast cancer using a combination of vitamin D analogues and other agents |
EP2249838A4 (en) * | 2008-02-05 | 2012-05-02 | Harbor Biosciences Inc | PHARMACEUTICAL FORMS IN SOLID STATE |
KR101841260B1 (ko) * | 2016-11-25 | 2018-03-23 | 정미영 | 재난 대피용 테이블 장치 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670190A (en) * | 1973-01-10 | 1987-06-02 | Hesse Robert H | 1-α-hydroxy vitamin D compounds and process for preparing same |
US3880894A (en) * | 1974-05-24 | 1975-04-29 | Wisconsin Alumni Res Found | 1,25-Dihydroxyergocalciferol |
US4022891A (en) * | 1974-06-18 | 1977-05-10 | Teijin Limited | Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them |
GB1583749A (en) * | 1976-06-03 | 1981-02-04 | Res Inst Medicine Chem | Vitamin d derivatives |
US4195027A (en) * | 1978-01-16 | 1980-03-25 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
US4338250A (en) * | 1981-04-27 | 1982-07-06 | Wisconsin Alumni Research Foundation | 1-Hydroxylation process |
US4719205A (en) * | 1984-01-30 | 1988-01-12 | Wisconsin Alumini Research Foundation | Side-chain unsaturated 1-hydroxyvitamin D compounds |
US4719204A (en) * | 1984-03-05 | 1988-01-12 | Wisconsin Alumni Research Foundation | Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs |
US5104864A (en) * | 1988-08-02 | 1992-04-14 | Bone Care International, Inc. | Method for treating and preventing loss of bone mass |
US5098899A (en) * | 1989-03-06 | 1992-03-24 | Trustees Of Boston University | Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites |
US4973584A (en) * | 1989-03-09 | 1990-11-27 | Deluca Hector F | Novel 1α-hydroxyvitamin D2 epimer and derivatives |
US5260290A (en) * | 1990-02-14 | 1993-11-09 | Wisconsin Alumni Research Foundation | Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives |
ES2134207T3 (es) * | 1991-01-08 | 1999-10-01 | Bone Care Int Inc | Procedimiento de preparacion y de utilizacion de la vitamina 1alfa,24-dihidroxi vitamina d2. |
-
1993
- 1993-08-30 JP JP50736194A patent/JP3179495B2/ja not_active Expired - Fee Related
- 1993-08-30 EP EP93921243A patent/EP0614456B1/en not_active Expired - Lifetime
- 1993-08-30 AT AT93921243T patent/ATE181062T1/de not_active IP Right Cessation
- 1993-08-30 WO PCT/US1993/008141 patent/WO1994005630A1/en active IP Right Grant
- 1993-08-30 DE DE69325253T patent/DE69325253T2/de not_active Expired - Lifetime
- 1993-08-30 AU AU48411/93A patent/AU4841193A/en not_active Abandoned
- 1993-08-30 DK DK93921243T patent/DK0614456T3/da active
- 1993-08-30 CA CA002121689A patent/CA2121689C/en not_active Expired - Lifetime
- 1993-08-30 ES ES93921243T patent/ES2134267T3/es not_active Expired - Lifetime
-
1997
- 1997-02-21 AU AU14864/97A patent/AU1486497A/en not_active Abandoned
-
1998
- 1998-12-14 US US09/211,984 patent/US6143910A/en not_active Expired - Lifetime
-
1999
- 1999-08-10 GR GR990402020T patent/GR3030939T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU1486497A (en) | 1997-05-22 |
DK0614456T3 (da) | 1999-12-06 |
DE69325253D1 (de) | 1999-07-15 |
DE69325253T2 (de) | 1999-12-02 |
EP0614456A4 (en) | 1995-01-04 |
JP3179495B2 (ja) | 2001-06-25 |
CA2121689A1 (en) | 1994-03-17 |
ATE181062T1 (de) | 1999-06-15 |
WO1994005630A1 (en) | 1994-03-17 |
US6143910A (en) | 2000-11-07 |
CA2121689C (en) | 2008-03-18 |
EP0614456B1 (en) | 1999-06-09 |
GR3030939T3 (en) | 1999-11-30 |
EP0614456A1 (en) | 1994-09-14 |
JPH07500848A (ja) | 1995-01-26 |
AU4841193A (en) | 1994-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2134207T3 (es) | Procedimiento de preparacion y de utilizacion de la vitamina 1alfa,24-dihidroxi vitamina d2. | |
ES2134267T3 (es) | 1alfa,24(s)-dihidroxi vitamina d2, su preparacion y utilizacion. | |
NO921955L (no) | Nye d-vitaminforbindelser og fremgangsmaate til fremstilling av samme | |
ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
MX9203050A (es) | Compuestos de analogos de triptamina. | |
DE69313128T2 (de) | Inhibitierung des haarwuchses | |
AR019823A1 (es) | Una composicion cosmetica para el cuidado de la piel y un metodo para reducir la irritacion o el picor de la piel | |
WO1994005630B1 (en) | 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE | |
ITRM930356A0 (it) | Uso di esteri sull'ossidrile della l-carnitina per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee. | |
MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
ATE193651T1 (de) | Therapeutisches system zur behandlung der psoriasis | |
ES2110057T3 (es) | Composicion medicinal que contiene tcf-ii. | |
YU17999A (sh) | Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu | |
MY103593A (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
DE50202865D1 (de) | Herstellung reiner stereoisomere von tricyclo-[5.2.1.0(2.6) ]-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel | |
ES2140544T3 (es) | Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas. | |
SE8107816L (sv) | Medel for lokal behandling av paverkan fran seborre pa menniskans huvudsval | |
MX9305151A (es) | Metodo para el tratamiento de enfermedades de la piel. | |
MX9204908A (es) | Composiciones farmaceuticas para el tratamiento de transtornos de la piel. | |
MX9300244A (es) | Derivados de difluorometilenandrostenona y proceso para su preparacion. | |
FI834737A0 (fi) | Nya kosmetiska kompositioner innehaollande prenylamin och foerfarande foer framstaellning av dessa | |
ES2100821A1 (es) | Composicion de un producto tonico armonizador del cuerpo humano aplicable sobre la piel. | |
NO903956D0 (no) | Sammensetninger som inneholder thymopentin til topisk behandling av hudsykdommer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 614456 Country of ref document: ES |